Further Weakness as Der Future Science and Technology Holding Group (SZSE:002631) Drops 14% This Week, Taking Three-year Losses to 18%
Further Weakness as Der Future Science and Technology Holding Group (SZSE:002631) Drops 14% This Week, Taking Three-year Losses to 18%
It can certainly be frustrating when a stock does not perform as hoped. But no-one can make money on every call, especially in a declining market. While the Der Future Science and Technology Holding Group Co., Ltd. (SZSE:002631) share price is down 20% in the last three years, the total return to shareholders (which includes dividends) was -18%. That's better than the market which declined 27% over the last three years. Furthermore, it's down 18% in about a quarter. That's not much fun for holders. But this could be related to the weak market, which is down 9.2% in the same period.
当股票表现不如预期时,肯定会令人沮丧。但是,没有人能在每次通话中赚钱,尤其是在下跌的市场中。尽管德尔未来科技控股集团有限公司(SZSE:002631)的股价在过去三年中下跌了20%,但股东总回报率(包括股息)为-18%。这比过去三年下跌27%的市场要好。此外,它在大约一个季度内下降了18%。对于持有者来说,这没什么好玩的。但这可能与疲软的市场有关,同期市场下跌了9.2%。
Given the past week has been tough on shareholders, let's investigate the fundamentals and see what we can learn.
鉴于过去一周对股东来说很艰难,让我们调查一下基本面,看看我们能学到什么。
See our latest analysis for Der Future Science and Technology Holding Group
查看我们对德尔未来科技控股集团的最新分析
There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.
不可否认,市场有时是有效的,但价格并不总是能反映潜在的业务表现。通过比较每股收益(EPS)和一段时间内的股价变化,我们可以了解投资者对公司的态度是如何随着时间的推移而变化的。
Der Future Science and Technology Holding Group saw its share price decline over the three years in which its EPS also dropped, falling to a loss. Due to the loss, it's not easy to use EPS as a reliable guide to the business. However, we can say we'd expect to see a falling share price in this scenario.
在三年中,德尔未来科学与技术控股集团的股价下跌,每股收益也下降至亏损。由于亏损,使用EPS作为可靠的业务指南并不容易。但是,我们可以说,在这种情况下,我们预计股价将下跌。
The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).
下图描述了 EPS 随着时间的推移是如何变化的(点击图片可以看到确切的值)。
![earnings-per-share-growth](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240124/0-5f2b0dd395414155da262874c61b53da-0-868742fa6ad83a74ed718a2303cf66c0.png/big)
We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. Dive deeper into the earnings by checking this interactive graph of Der Future Science and Technology Holding Group's earnings, revenue and cash flow.
我们很高兴地向大家报告,首席执行官的薪酬比资本相似公司的大多数首席执行官要适中。但是,尽管首席执行官的薪酬总是值得检查的,但真正重要的问题是公司未来能否增加收益。查看这张德尔未来科技控股集团收益、收入和现金流的互动图表,深入了解收益。
A Different Perspective
不同的视角
Although it hurts that Der Future Science and Technology Holding Group returned a loss of 9.8% in the last twelve months, the broader market was actually worse, returning a loss of 21%. Unfortunately, last year's performance may indicate unresolved challenges, given that it's worse than the annualised loss of 3% over the last half decade. Whilst Baron Rothschild does tell the investor "buy when there's blood in the streets, even if the blood is your own", buyers would need to examine the data carefully to be comfortable that the business itself is sound. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should be aware of the 1 warning sign we've spotted with Der Future Science and Technology Holding Group .
尽管德尔未来科技控股集团在过去十二个月中回报了9.8%的亏损令人痛心,但整个市场实际上更糟,回报了21%的亏损。不幸的是,去年的表现可能预示着尚未解决的挑战,因为它比过去五年中3%的年化亏损还要糟糕。尽管罗斯柴尔德男爵确实告诉投资者 “街上有血时买入,即使血液是你自己的”,但买家需要仔细检查数据,以确定业务本身是健全的。我发现将长期股价视为业务绩效的代表非常有趣。但是,要真正获得见解,我们还需要考虑其他信息。为此,你应该注意我们在德尔未来科技控股集团发现的1个警告标志。
For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.
对于那些喜欢寻找中奖投资的人来说,这份最近有内幕收购的成长型公司的免费名单可能只是门票。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
请注意,本文引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。